Home
About
Product
magNews
Career
Contact Us
中文
English
magNews
Corporate
Industry
Technology
Medical Updates
Corporate
Redefining New Boundaries in Delivering Patient Care
2025-01-24
Corporate
magAssist Recognized in 2024 VENTURE50 Awards
2025-01-09
Corporate
MoyoAssist® Extra-VAD® Introduces Fully Magnetically Levitated Extracorporeal Heart Support Technology in China
2024-06-28
Corporate
MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held
2024-06-24
2022 list of China's most socially impactful startups
Corporate
Redefining New Boundaries in Delivering Patient Care
2025-01-24
Corporate
magAssist Recognized in 2024 VENTURE50 Awards
2025-01-09
Corporate
magAssist was included in the catalogue of "Advantageous Enterprises in the Fourth Batch of Intellectual Property Strong Companies Cultivation Project in Suzhou City".
2024-12-20
Corporate
MoyoAssist® Extra-VAD® Introduces Fully Magnetically Levitated Extracorporeal Heart Support Technology in China
2024-06-28
Corporate
MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held
2024-06-24
Corporate
NMPA grants approval to MoyoAssist® China's first full maglev extracorporeal VAD
2024-05-14
Corporate
First Patient with NyokAssist™ Interventional Ventricular Assist Device: Dr. Junbo Ge's team successfully completed the first high-risk PCI treatment supported by the new generation of interventi
2023-09-05
Corporate
magAssist ECMO approved in the Transformation of Scientific and Technological Achievements Special Fund
2023-08-28
Corporate
magAssist Attains Recognition as the Most Innovative Medical Device Product of 2023
2023-08-21
Corporate
magAssist's NyokAssist™ granted Designation by the FDA as a Breakthrough Device
2023-08-17
1
2
3
4
5
···
1/9
》
Tags:
Innovation,
Application,
Extra-VAD,
U.S. FDA,
Interventional Ventricular Assist Device,
Breakthrough Device,
VENTURE50,
Awards,
Healthcare,
Difference,
TOP